Page last updated: 2024-09-02

ecopipam and Substance Withdrawal Syndrome

ecopipam has been researched along with Substance Withdrawal Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davidson, C; Ellinwood, EH; Gao, WY; Lee, TH	1

Other Studies

1 other study(ies) available for ecopipam and Substance Withdrawal Syndrome

Article	Year
Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 21, Issue:1 Topics: Animals; Apomorphine; Benzazepines; Cocaine-Related Disorders; Dopamine; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Male; Mesencephalon; Neurons; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance Withdrawal Syndrome; Substantia Nigra; Ventral Tegmental Area	1999

Article

Year

Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 21, Issue:1

Topics: Animals; Apomorphine; Benzazepines; Cocaine-Related Disorders; Dopamine; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Male; Mesencephalon; Neurons; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance Withdrawal Syndrome; Substantia Nigra; Ventral Tegmental Area

1999